Crinetics director granted RSUs and stock options
Crinetics Pharmaceuticals director Camille L. Bedrosian reported receiving new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Crinetics Pharmaceuticals director Camille L. Bedrosian reported receiving new equity awards. She was granted 5,925 restricted stock units representing rights to receive Common Stock, vesting 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual stockholder meeting, subject to continued board service.
She also received stock options for 9,730 shares of Common Stock at an exercise price of $35.87 per share, expiring on June 18, 2036, with the same vesting schedule. After these awards, she directly holds 22,225 shares of Common Stock and 9,730 options.
Insider Trade Summary
Grant/Award: 15,655 shares
Grant/Award
2 txns
Insider
Bedrosian Camille L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,730 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,925 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,730 contracts (Direct);
Common Stock — 22,225 shares (Direct)
Footnotes (2)
- F1. The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- F2. The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Restricted stock units granted: 5,925 units
Stock options granted: 9,730 options
Option exercise price: $35.87 per share
+3 more
6 metrics
Restricted stock units granted
5,925 units
Grant of RSUs on June 18, 2026 with time-based vesting
Stock options granted
9,730 options
Right to buy Common Stock, granted June 18, 2026
Option exercise price
$35.87 per share
Exercise price for 9,730 stock options
Option expiration date
June 18, 2036
Expiration of granted stock options
Shares held after awards
22,225 shares
Direct Common Stock ownership following the grants
Options held after awards
9,730 options
Total options following this grant
Key Terms
restricted stock units, stock option, vest, annual meeting of the Issuer's stockholders, +1 more
5 terms
restricted stock units financial
"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of the Issuer's stockholders financial
"the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service..."
exercise price financial
"Stock Option (Right to Buy)... conversion_or_exercise_price: "35.8700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Crinetics Pharmaceuticals (CRNX) report for Camille L. Bedrosian?
Crinetics reported that director Camille L. Bedrosian received new equity awards, including 5,925 restricted stock units and options for 9,730 shares. These awards are tied to her continued service on the company’s board of directors and follow a time-based vesting schedule.
How many restricted stock units did Camille L. Bedrosian receive from Crinetics (CRNX)?
She received 5,925 restricted stock units representing the right to receive shares of Common Stock. These units will vest 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual meeting, assuming continued board service.
What are the terms of the stock options granted to Camille L. Bedrosian by Crinetics (CRNX)?
She was granted options for 9,730 shares of Common Stock at an exercise price of $35.87 per share. The options vest on the same schedule as the restricted stock units and expire on June 18, 2036, giving a long exercise window after vesting.
When do Camille L. Bedrosian’s Crinetics (CRNX) equity awards vest?
Both the restricted stock units and stock options vest 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual stockholder meeting. Vesting is conditioned on her continued service on Crinetics’ board through the vesting date.
Is Camille L. Bedrosian’s Crinetics (CRNX) transaction a purchase or a grant?
The Form 4 lists the transactions under code “A,” meaning a grant, award, or other acquisition. The filing describes them as restricted stock units and stock options granted in connection with her role on the board, rather than open-market share purchases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates